Optibrium - Optibrium creates elegant software solutions for small molecule design, optimisation and data analysis

Skip to the content

New Publication:

Imputing Bioactivity Data using Deep
Learning. Read the paper >

Next Event:

25-29 August, ACS National Fall Meeting,
San Diego, CA, USA. More >

Predicting pKa Using a Combination of Quantum and Machine Learning Methods by Peter Hunt
Predicting Routes, Sites and Products of Drug Metabolism by Matt Segall
A Single Deep Learning Model for Confident Imputation of Heterogeneous Drug Discovery Endpoints by Matt Segall

Copyright © 2019 Optibrium, Ltd. All Rights Reserved.
Optibrium™, StarDrop™, Augmented Chemistry™, Asteris™, Ocura™, Glowing Molecule™, WhichP450™, Auto-Modeller™, Nova™, MPO Explorer™ and Card View™ are trademarks of Optibrium Ltd. Matsy™ is a trademark of NextMove Software Ltd., BIOSTER™ is a trademark of iKem Szolgáltató és Kereskedelmi BT, Derek Nexus™ is a trademark of Lhasa Ltd., torch3D™ is a trademark of Cresset BioMolecular Discovery Ltd., and SeeSAR™ is a trademark of BioSolveIT GmbH.
US Patent Numbers 9,224,098 and 9,367,812

New Publication:

Imputing Bioactivity Data using DeepLearning. Read the paper >

Next Event:

25-29 August, ACS National Fall Meeting, San Diego, CA, USA. More >

Imputing Bioactivity Data using Deep
Learning. Read the paper >

25-29 August, ACS National Fall Meeting,
San Diego, CA, USA. More >